Literature DB >> 19737152

Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study.

R Loomba1, R Bettencourt, E Barrett-Connor.   

Abstract

BACKGROUND: The association between body-mass-index (BMI), alcohol consumption and their joint effect in increasing the risk of elevated serum alanine (ALT) and aspartate (AST) is unclear in older community-dwelling adults. AIM: To determine the association between alcohol, BMI, and their combined effect with serum ALT and AST in older community-dwelling adults in the United States.
METHODS: A cross-sectional, population-based study in participants (n = 2364) from the Rancho Bernardo Study (54% women; mean age: 70 years, BMI: 25 kg/m(2), alcohol users: 63%) who attended a research visit in 1984-87. BMI was recorded by a trained nurse and alcohol use ascertained by a validated questionnaire. Odds-ratio (OR) and 95% confidence intervals (CI) of elevated serum ALT and AST (defined as > or =30 U/L in men and > or =19 U/L in women) were calculated for alcohol and BMI separately and their joint exposure using logistic regression models.
RESULTS: In multivariate logistic regression models adjusted for age, alcohol use, total cholesterol, serum triglycerides, fasting plasma glucose, systolic blood pressure, and diabetes mellitus, obesity independently increased the odds of elevated ALT in this cohort of older men and women by 3.0 (95% CI, 1.7-5.3) and 1.8 (95% CI, 1.1-2.7) respectively. Joint effects of consuming >3 alcoholic drinks/day and obesity raised the odds of elevated ALT by 8.9 (95% CI, 2.4-33.1) and AST by 21-fold (95% CI, 2.6-170.1), demonstrating synergism. Obese participants had higher odds of elevated ALT even at 0 < or = 1 drink/day.
CONCLUSIONS: In older men and women, the combination of obesity with alcohol is synergistic in increasing the risk of liver injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737152      PMCID: PMC3220929          DOI: 10.1111/j.1365-2036.2009.04141.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  37 in total

1.  The effects of obesity, smoking, and drinking on medical problems and costs.

Authors:  Roland Sturm
Journal:  Health Aff (Millwood)       Date:  2002 Mar-Apr       Impact factor: 6.301

Review 2.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation.

Authors:  Ayman Koteish; ShiQi Yang; HuiZhi Lin; Xiawen Huang; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study.

Authors:  D H Lee; M H Ha; D C Christiani
Journal:  Int J Epidemiol       Date:  2001-08       Impact factor: 7.196

Review 6.  Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.

Authors:  Min You; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07       Impact factor: 4.052

7.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

8.  Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.

Authors:  Naga Chalasani; Mark A Deeg; David W Crabb
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

9.  Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.

Authors:  Rohit Loomba; Shih-Jen Hwang; Christopher J O'Donnell; R Curtis Ellison; Ramachandran S Vasan; Ralph B D'Agostino; T Jake Liang; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  44 in total

1.  Serum γ-glutamyltranspeptidase predicts all-cause, cardiovascular and liver mortality in older adults.

Authors:  Rohit Loomba; Iliana Doycheva; Ricki Bettencourt; Benjamin Cohen; Christina L Wassel; David Brenner; Elizabeth Barrett-Connor
Journal:  J Clin Exp Hepatol       Date:  2013-03-01

Review 2.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

3.  Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men.

Authors:  Raquel Villegas; Yong-Bing Xiang; Tom Elasy; Qiuyin Cai; Wanghong Xu; Honglan Li; Sergio Fazio; Macrae F Linton; David Raiford; Wei Zheng; Xiao Ou Shu
Journal:  Metab Syndr Relat Disord       Date:  2011-04-15       Impact factor: 1.894

4.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

5.  Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.

Authors:  Binxia Chang; Ming-Jiang Xu; Zhou Zhou; Yan Cai; Man Li; Wei Wang; Dechun Feng; Adeline Bertola; Hua Wang; George Kunos; Bin Gao
Journal:  Hepatology       Date:  2015-07-03       Impact factor: 17.425

Review 6.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

7.  Review of current clinical biomarkers for the detection of alcohol dependence.

Authors:  Hamid R Tavakoli; Michael Hull; Lt Michael Okasinski
Journal:  Innov Clin Neurosci       Date:  2011-03

8.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 9.  Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).

Authors:  Helmut K Seitz; Sebastian Mueller; Claus Hellerbrand; Suthat Liangpunsakul
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

10.  Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

Authors:  Mamie H Dong; Ricki Bettencourt; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.